Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
According to the data derived from several national and international registries, including SANI (Severe Asthma Network Italy), and considering the strong impact that frequent or regular use of oral corticosteroid has on quality of life (QoL) of severe asthmatics, as well as on the costs for managin...
פריטים דומים
-
Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey
מאת: Claudia Crimi, et al.
יצא לאור: (2023-11-01) -
Nasal polyps impact in severe asthma patients: evidences from the SANI
מאת: Giorgio Walter Canonica, et al.
יצא לאור: (2020-08-01) -
Economic impact of a more extensive use of FENO testing on the Italian population with asthma
מאת: Carla Rognoni, et al.
יצא לאור: (2023-06-01) -
Asthma severity: the patient’s point of view
מאת: Gabriella Guarnieri, et al.
יצא לאור: (2024-12-01) -
Is Bronchiectasis (BE) Properly Investigated in Patients with Severe Asthma? A Real-Life Report from Eight Italian Centers
מאת: Giovanna Elisiana Carpagnano, et al.
יצא לאור: (2023-10-01)